Leqvio vs. Livalo

See how Leqvio and Livalo compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Leqvio is a twice-yearly injection that silences PCSK9 production in the liver, while Livalo is a daily statin pill that blocks cholesterol synthesis directly.

  • Both drugs lower LDL cholesterol, but Leqvio must be injected by a healthcare provider and Livalo is a tablet patients take at home on their own.

  • Livalo has more than a decade of statin safety data and a lower monthly price, while Leqvio offers far less frequent dosing but no generic option.

Leqvio vs. Livalo Drug Summary

Leqvio

Leqvio (inclisiran) is a PCSK9 synthesis inhibitor given as a subcutaneous injection to lower LDL cholesterol in adults with high cholesterol or certain inherited forms of high cholesterol. After two starting doses, it only needs to be injected twice a year by a healthcare provider.

Livalo

Livalo (pitavastatin) is a statin that blocks an enzyme in the liver needed to make cholesterol, lowering LDL, total cholesterol, and triglycerides. It comes as a tablet taken once a day, usually starting at a low dose that can be adjusted based on response.

Leqvio vs. Livalo Side Effects

Leqvio

Most common
injection site reaction (up to 3%)
arthralgia (up to 3%)
bronchitis (up to 3%)

Livalo

Most common
back pain (up to 3.9%)
constipation (up to 3.6%)
myalgia (up to 3.1%)

Leqvio vs. Livalo Dosage

Leqvio

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 284 mg injection Day 1
Maximum dose 284 mg injection Same as starting
Dose changes None Fixed dose

Livalo

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 1 mg once daily At the start
Maximum dose 4 mg once daily If needed
Dose changes 2 increases As tolerated

Leqvio vs. Livalo Indications

Leqvio

Leqvio is FDA-approved as an add-on to diet and exercise to lower LDL cholesterol in adults with high cholesterol, including those with heterozygous familial hypercholesterolemia. It is also approved for patients 12 and older with heterozygous or homozygous familial hypercholesterolemia. It is not approved as a stand-alone treatment for acute cardiovascular events.

  • Adults with primary hyperlipidemia

  • Adults and teens 12+ with heterozygous FH

  • Teens 12+ with homozygous FH

  • Used alongside diet and exercise, not alone

Livalo

Livalo is FDA-approved as an add-on to diet to lower LDL cholesterol, total cholesterol, apolipoprotein B, and triglycerides in adults with high cholesterol or mixed dyslipidemia. It is also approved for heterozygous familial hypercholesterolemia in adults and children as young as 8. Some clinicians also prescribe it off-label for primary prevention of atherosclerotic cardiovascular disease.

  • Adults with primary hyperlipidemia or mixed dyslipidemia

  • Adults with heterozygous FH

  • Children 8+ with heterozygous FH

  • Off-label: primary ASCVD prevention

Leqvio vs. Livalo Pros and Cons

Leqvio

Leqvio's twice-yearly dosing after the first two injections makes it appealing for patients who struggle with daily pills or want fewer touchpoints with their treatment. It must be given by a healthcare provider, and coverage can be inconsistent since it is a newer, costlier therapy.

Pros

  • Only 2 doses in year one, then 1 injection every 6 months

  • Avoids daily pill burden entirely

  • Different mechanism than statins, useful if statins aren't tolerated

  • Approved down to age 12 for familial hypercholesterolemia

Cons

  • Must be administered by a healthcare provider, not self-injected

  • No long-term cardiovascular outcomes data yet

  • Newer drug with less real-world safety history

  • Insurance approval can be difficult due to high cost

Livalo

Livalo has been used since 2009, giving prescribers decades of statin safety and outcomes data to draw on. It requires a daily pill and carries the familiar statin risks of muscle pain and liver enzyme changes, but has fewer drug interactions than many other statins.

Pros

  • Decades of statin safety and outcomes data

  • Minimal CYP3A4 metabolism means fewer drug interactions

  • Taken and adjusted at home without office visits

  • Approved for children as young as 8 with familial hypercholesterolemia

Cons

  • Requires taking a pill every single day

  • Carries statin risks of myopathy and rare rhabdomyolysis

  • Contraindicated with cyclosporine and active liver disease

  • No generic version currently available, unlike most statins

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.